<DOC>
	<DOCNO>NCT00361452</DOCNO>
	<brief_summary>Bronchiolitis common disease infancy main reason infant ' hospital admission first 2 year life . The main cause bronchiolitis RSV ( respiratory syncytial virus ) . Though , Treatment mainly supportive , treatment benefit nebulized epinephrine albuterol largely debate past year . Most clinical study use clinical parameter detect compare effectiveness medical intervention . In study use non invasive computerize method wheeze crackle quantification compare effectiveness nebulized epinephrine v albuterol RSV Bronchiolitis .</brief_summary>
	<brief_title>Acoustic Assessment Nebulized Epinephrine Versus Albuterol RSV Bronchiolitis- Double Blind Study</brief_title>
	<detailed_description>Inpatient Infants young 2 year age first episode RSV bronchiolitis randomly assign treatment nebulized epinephrine ( 1 mg dilute 3 ml 0.9 % saline ) nebulized albuterol ( 2.5 mg dilute 3.5 ml 0.9 % saline ) . Both solution provide identical container . Clinical assessment clinical score do treatment , 10 30 minute treatment . The following parameter record time point , wheeze , respiratory distress , O2 saturation , respiratory rate heart rate . Computerized lung sound well , record treatment , 10 30 minute treatment via 4 contact sensor attach chest .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Under one year age first episode wheeze dyspnea RSV antigen detect ELISA parent sign informed consent . infant chronic lung disease cardiac disease chronic condition .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>November 2000</verification_date>
</DOC>